EcoDrugPlus

Ensembl ID : ENSCARG00000031022
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSCARG00000031888
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSCARG00000015438
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSCARG00000003847
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSCARG00000030574
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSCARG00000023001
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSCARG00000030409
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSCARG00000034150
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSCARG00000048354
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSCARG00000004011
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSCARG00000017720
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSCARG00000026377
Gene Symbol: -
Cross references: -
128 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).